Healthcare -
Biotechnology - NASDAQ - US
$ 43.84
1.76 %
$ 3.38 B
Market Cap
-7.38
P/E
PTCT - REVENUE
Revenue PTCT - PTC Therapeutics, Inc.
938 M
LAST VALUE
31.96%
2 YEAR CAGR
28.78%
5 YEAR CAGR
40.48%
10 YEAR CAGR